How To Speak REMS: Structured Product Labeling Seen As Route To Standardization

“Before we can standardize REMS we need to have that common language to describe what’s in the REMS,” FDA’s Adam Kroetsch says.

Structured Product Labeling is gaining momentum as the path to standardized Risk Evaluation and Mitigation Strategies.

FDA, drug companies and other stakeholders in the health care system view standardization as the best way to lower the burden of REMS on health care providers while ensuring the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America